Peripheral Artery Disease Market Size, Trends and Growth Analysis by Treatment Type (Devices (Angioplasty Balloon, Angioplasty Stents (Stenting), Catheters, Plaque Modification Devices (Atherectomy), Hemodynamic Flow Alteration Devices, Others), Drugs (Lipid-Lowering Drugs, Blood Pressure Lowering Drugs, Glucose Regulating Drugs, Blood Clot Preventing Drugs)) End User (Hospitals and Clinics, Ambulatory Surgery Centers and others) and Region (Americas, Europe, Asia-Pacific & Middle East & Africa) – Forecast till 2025
Peripheral Artery Disease Market Scope
Peripheral artery disease market size can potentially achieve a CAGR of 4.84% between 2016 and 2025 (appraisal period), claims MRFR/Market Research Future. MRFR also anticipates the peripheral artery disease market size to touch USD 23,624.01 Million by 2025. We will provide COVID-19 impact analysis with the report, along with all the extensive key developments in the market post the coronavirus disease outbreak.
Factors including rapid expansion of the geriatric populace and the subsequent rise in cases of peripheral artery diseases have been favorable for the global peripheral artery disease market in recent years. Increased prevalence of high blood pressure and diabetes could also benefit the global market, since these diseases increase the risk of contracting the peripheral artery disease. Supportive reimbursement schemes available across countries for the treatment of peripheral artery disease and the frequent introduction of innovative treatment devices like drug-eluting stents are also projected to bolster the market growth in the following years.
Request Free Sample Copy of the report “Global Peripheral Artery Disease Market Research Report—Forecast till 2025” at: https://www.marketresearchfuture.com/sample_request/1540
Some of the peripheral artery disease market trends include the rising preference for minimally or non-invasive endovascular surgical procedures since they facilitate lower recovery time, less scarring, and reduced chances of acquiring post-surgery infections. Surge in lifestyle diseases in line with the rising prevalence of unhealthy eating habits including tobacco and alcohol, will also enhance the peripheral artery disease market size in the coming years. In the years ahead, the peripheral vascular devices market could receive a substantial boost from the escalating cases of blood clotting, cardiac arrests, and various vascular diseases.
Many of the companies are engaged in partnerships and agreements to garner higher dominance over the peripheral artery disease market. Increasing approvals by FDA and other healthcare authorities are encouraging players to focus on innovations and introduction of new and more advanced devices. A case in point, in November 2020, FDA gave the green light to Boston Scientific’s newly developed paclitaxel-coated Ranger balloon designed for peripheral artery disease in the popliteal artery behind the knee and the femoral artery that is present in the upper thigh.
Peripheral Artery Disease Market Segmental Insight
Peripheral artery disease market can be considered for treatment type and end user.
The various treatment types available worldwide are drugs and devices.
The top end-users in the peripheral artery disease industry are ambulatory surgery centers, hospitals and clinics, and more.
Peripheral Artery Disease Market Regional Outlook
Europe and the Americas along with MEA/Middle East and Africa as well as APAC/Asia Pacific are the key peripheral artery disease market.
Since 2018, the Americas continues leading the global peripheral artery disease market, backed by the significant growth rate of diabetes, high healthcare spending and the high prevalence of obesity. The constantly evolving lifestyle habits that include bad diet, excessive consumption of tobacco and alcohol, and lack of exercise have made people in the region extremely vulnerable to the peripheral artery disease, resulting in robust market growth. It is alto projected that the United States peripheral vascular devices market can perform well in the coming years, thanks to the emerging trend of minimally-invasive surgical procedures, rise in technical innovations and the substantial investments by public as well as private organizations this field.
In the global peripheral artery disease market, Europe is in the second place, while Western Europe contributes the most to the said growth. The regional peripheral artery disease market sturdy expansion rate in the coming years is expected to be the outcome of the surge in cardiovascular disorders and the burgeoning pool of smokers. The growing elderly population also boosts revenue generation in the region.
APAC represents the highest growth potential on account of the rising per capita income and rise in government initiatives focused on improving the healthcare system. The escalating number of diabetes cases and the booming geriatric population has made India, Australia and China the most profitable markets in the region. Many of the emerging countries in the region are expected to observe notable growth over the ensuing years due to the presence of lenient regulatory norms and low intensity of competition between the players. With the intention of leveraging the attractive opportunities present in these countries, manufacturers are striving to expand their presence by adopting agreements, partnerships and product launches as key growth strategies.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/peripheral-artery-disease-market-1540
Peripheral Artery Disease Market Top Competitors
Top competitors active in the worldwide peripheral artery disease market are Becton, Dickinson and Company (BD) (US), Biotronik (Germany), Cardinal Health (US), Bayer AG (Germany), Cook (US), B. Braun Melsungen AG (Germany), Medtronic (Ireland), Boston Scientific Corporation (US), Terumo Medical Corporation (Japan), Koninklijke Philips NV (Netherlands), and more.
NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
+1 646 845 9312